Valneva SE

EPA:VLA.PA

3.13 (EUR) • At close September 6, 2024
Bedrijfsnaam Valneva SE
Symbool VLA.PA
Munteenheid EUR
Prijs 3.08
Beurswaarde 428,590,248
Dividendpercentage 0%
52-weken bereik 2.93 - 7.168
Industrie Biotechnology
Sector Healthcare
CEO Mr. Thomas Lingelbach
Website https://valneva.com

An error occurred while fetching data.

Over Valneva SE

Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention

Vergelijkbare Aandelen

Fagron NV logo

Fagron NV

FAGR.BR

19.12 EUR

Faes Farma, S.A. logo

Faes Farma, S.A.

FAE.MC

3.67 EUR

Arvida Group Limited logo

Arvida Group Limited

ARV.NZ

1.21 NZD

Riverstone Holdings Limited logo

Riverstone Holdings Limited

AP4.SI

0.885 SGD

Pharma Mar, S.A. logo

Pharma Mar, S.A.

PHM.MC

40.76 EUR

Uniphar plc logo

Uniphar plc

UPR.IR

2.61 EUR

Vetoquinol SA logo

Vetoquinol SA

VETO.PA

91.6 EUR

Orpea SA logo

Orpea SA

ORP.PA

12.312 EUR

Boiron SA logo

Boiron SA

BOI.PA

32.15 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)